InDex Pharmaceuticals Holding AB (publ)
SSE:INDEX.ST
0.244 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||
Net Income
| -95.265 | -103.227 | -102.91 | -57.349 | -87.712 | -82.315 | -72.759 | -41.275 | -29.881 | -10.395 |
Depreciation & Amortization
| 1.216 | 1.066 | 1.252 | 1.192 | 0.939 | 0.011 | 0.011 | 0.067 | 0.095 | 0.111 |
Deferred Income Tax
| -0.758 | -0.536 | -0.374 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0.758 | 0.536 | 0.374 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 44.239 | 16.341 | -10.36 | -14.423 | 1.753 | 2.805 | 4.536 | 9.338 | -7.176 | 6.544 |
Accounts Receivables
| 0.068 | 12.172 | -10.648 | -2.117 | 0.151 | 0 | 0 | 0 | 0 | 0 |
Inventory
| -44.171 | 0 | -0.288 | 12.306 | -1.602 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 44.171 | 4.169 | 0.288 | -12.306 | 1.602 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 44.171 | 0 | 0.288 | -12.306 | 1.602 | 0 | 0 | 0 | 0 | 0 |
Other Non Cash Items
| 11.075 | -43.622 | -12.04 | -0.07 | -0.061 | 1 | 0.027 | 0 | 0 | -4.475 |
Operating Cash Flow
| -37.977 | -129.442 | -124.058 | -70.65 | -85.081 | -78.499 | -68.185 | -31.87 | -36.962 | -8.215 |
Investing Activities: | ||||||||||
Investments In Property Plant And Equipment
| 0 | 0 | 0 | -0.909 | 0 | 0 | 0 | -0.053 | 0 | 0 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| 0 | 0 | 0 | -0.909 | 0 | 0 | 0 | -0.053 | 0 | 0 |
Financing Activities: | ||||||||||
Debt Repayment
| -1.028 | -0.818 | -1.103 | -1.639 | -0.947 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 487.495 | 0.242 | 129.784 | 37.478 | 0.008 | 218.195 | 0.03 | 30.162 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -1.028 | -0.818 | 486.392 | -1.397 | 128.837 | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow
| -1.028 | -0.818 | 486.392 | -1.397 | 128.837 | 37.478 | 0.008 | 218.195 | 0.03 | 30.162 |
Other Information: | ||||||||||
Effect Of Forex Changes On Cash
| -11.659 | 46.742 | 12.281 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -50.664 | -83.518 | 374.615 | -72.956 | 43.756 | -42.021 | -68.177 | 186.272 | -36.932 | 21.947 |
Cash At End Of Period
| 294.267 | 344.931 | 428.449 | 53.834 | 126.79 | 83.034 | 125.055 | 193.232 | 6.96 | 43.892 |